Literature DB >> 21874641

Acute glomerulonephritis: a 7 years follow up of children in center of Iran.

Mohsen Akhavan Sepahi1, Ahmad Shajari, Mehrdad Shakiba, Fatemeh Khalife Shooshtary, Mohammad Hossein Salimi.   

Abstract

Acute glomerulonephritis (AGN) is a type of renal disease which indicates the inflammation of glomerulus and nephrons. This study was carried on 94 children, <15 years old with the diagnosis of AGN who were admitted to Qom and Yazd's hospitals between 2000 and 2006. Data were collected using hospital records on admission, progression notes and outpatient follow up. Among 94 patients, 55.3% were male and 44.6% were female. Mean age of patients was 8.2±2.7 years old. Acute post streptococcal glomerulonephritis (APSGN) was reported in 92.5%, membranoproliferative glomerulonephritis in 4.2%, hemolytic uremic syndrome in 2.1% and IgA nephropathy in 1.06%. There was no significant differences between GN types and gender (P=0.54). Clinical manifestation included edema in 68.8%, oliguria in 36.3%, gross hematuria in 69.1%, HTN in 61.7% and anuria in 1.06%. Microscopic hematuria was detected in all patients. In the time of follow up none of patients had hypertension, 3.1% had proteinuria and 6.3% had microscopic hematuria. APSGN is the most common causes of AGN in Qom and Yazd's children. Early diagnosis and treatment of APSGN may protect children from long term morbidity and mortality and improve quality of life.

Entities:  

Mesh:

Year:  2011        PMID: 21874641

Source DB:  PubMed          Journal:  Acta Med Iran        ISSN: 0044-6025


  2 in total

Review 1.  A Comprehensive Review Study on Glomerulonephritis Associated With Post-streptococcal Infection.

Authors:  Mustafa A Alhamoud; Ibrahim Z Salloot; Shamim S Mohiuddin; Turki M AlHarbi; Faisal Batouq; Naif Y Alfrayyan; Ahmad I Alhashem; Mohammad Alaskar
Journal:  Cureus       Date:  2021-12-06

Review 2.  Management and outcomes of acute post-streptococcal glomerulonephritis in children.

Authors:  Leong Tung Ong
Journal:  World J Nephrol       Date:  2022-09-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.